Elizabeth Oseku

Elizabeth Oseku

Auto-generated profile, based on publicly available information

Elizabeth Oseku

Academy for Health Innovation Uganda, Infectious Diseases Institute, Makerere University, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
DBDathan Byonanebye
Dathan Byonanebye
MNMaria S Nabaggala
Maria S Nabaggala
ANAgnes Bwanika Naggirinya
Agnes Bwanika Naggirinya
MLMohammed Lamorde
Mohammed Lamorde
EOElizabeth Oseku
Elizabeth Oseku
RPRosalind Parkes-Ratanshi
Rosalind Parkes-Ratanshi
Background: Following the successful scale-up of antiretroviral therapy (ART), the focus is now on ensuring good quality of life (QoL) and sustained viral suppression in people living with HIV. The access to mobile technology in the most burdened countries is increasing rapidly, and therefore, mobile health (mHealth) technologies could be leveraged to improve QoL in people living with HIV. However, data on the impact of mHealth tools on the QoL in people living with HIV are limited to the evaluation of SMS text messaging; these are infeasible in high-illiteracy settings. Objective: The primary and secondary outcomes were to determine the impact of interactive voice response (IVR) technology on Medical Outcomes Study HIV QoL scores and viral suppression at 12 months, respectively. Methods: Within the Call for Life study, ART-experienced and ART-naïve people living with HIV commencing ART were randomized (1:1 ratio) to the control (no IVR support) or intervention arm (daily adherence and pre-appointment reminders, health information tips, and option to report symptoms). The software evaluated was Call for Life Uganda, an IVR technology that is based on the Mobile Technology for Community Health open-source software. Eligibility criteria for participation included access to a phone, fluency in local languages, and provision of consent. The differences in differences (DIDs) were computed, adjusting for baseline HIV RNA and CD4. Results: Overall, 600 participants (413 female, 68.8%) were enrolled and followed-up for 12 months. In the intervention arm of 300 participants, 298 (99.3%) opted for IVR and 2 (0.7%) chose SMS text messaging as the mode of receiving reminders and health tips. At 12 months, there was no overall difference in the QoL between the intervention and control arms (DID=0.0; P=.99) or HIV RNA (DID=0.01; P=.94). At 12 months, 124 of the 256 (48.4%) active participants had picked up at least 50% of the calls. In the active intervention participants, high users (received >75% of reminders) had overall higher QoL compared to low users (received <25% of reminders) (92.2 versus 87.8, P=.02). Similarly, high users also had higher QoL scores in the mental health domain (93.1 versus 86.8, P=.008) and better appointment keeping. Similarly, participants with moderate use (51%-75%) had better viral suppression at 12 months (80/94, 85% versus 11/19, 58%, P=.006). Conclusions: Overall, there was high uptake and acceptability of the IVR tool. While we found no overall difference in the QoL and viral suppression between study arms, people living with HIV with higher usage of the tool showed greater improvements in QoL, viral suppression, and appointment keeping. With the declining resources available to HIV programs and the increasing number of people living with HIV accessing ART, IVR technology could be used to support patient care. The tool may be helpful in situations where physical consultations are infeasible, including the current COVID epidemic. Trial Registration: ClinicalTrials.gov NCT02953080; https://clinicaltrials.gov/ct2/show/NCT02953080

26 February 2022 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
ANAgnes Bwanika Naggirinya
Agnes Bwanika Naggirinya
EKEunice L. Kyomugisha
Eunice L. Kyomugisha
MNMaria S. Nabaggala
Maria S. Nabaggala
BNBenson Nasasira
Benson Nasasira
JAJosephine Akirana
Josephine Akirana
RPRosalind Parkes-Ratanshi
Rosalind Parkes-Ratanshi
Evidence shows benefit of digital technology for people living with human immunodeficiency virus on antiretroviral therapy adherence and retention in care, however, scalability and sustainability have scarcely been evaluated. We assessed participants’ willingness to pay a fee for mHealth “Call for life Uganda” support, a mobile-phone based tool with the objective to assess sustainability and scalability. “Call for Life study”, approved by Makerere University, School of Public Health research & ethics committee, at 2 sites in Uganda, evaluated a MoTech based software “CONNECT FOR LIFE™” mHealth tool termed “Call for life Uganda”. It provides short messages service or Interactive Voice Response functionalities, with a web-based interface, allows a computer to interact with humans through use of voice and tones input via keypad. Participants were randomized at 1:1 ratio to Standard of Care or standard of care plus Call for life Uganda. This sends pill reminders, visit reminders, voice messages and self-reported symptom support. At study visits 18 and 24 months, through mixed method approach we assessed mHealth sustainability and scalability. Participants were interviewed on desire to have or continue adherence support and willingness to pay a nominal fee for tool. We computed proportions willing to pay (± 95% confidence interval), stratified by study arm and predictors of willingness to continue and to pay using multivariate logistic regression model backed up by themes from qualitative interviews. 95% of participants were willing to continue using C4LU with 77.8% willing to pay for the service. Persons receiving care at the peri-urban clinic (OR 3.12, 95% CI 1.43–9.11.86) and those with exposure to the C4LU intervention (OR 4.2, 95% CI 1.55–11.84) were more likely to continue and pay for the service. Qualitative interviews revealed mixed feelings regarding amounts to pay, those willing to pay, argued that since they have been paying for personal phone calls/messages, they should not fail to pay for Call for life. Payment for the service offers opportunities to scale up and sustain mHealth interventions which may not be priorities for government funding. A co-pay model could be acceptable to PLHIV to access mHealth services in low resource settings. Clinical Trial Number NCT 02953080.

1 August 2020 in JMIR Preprints
Verified
Preprint
Open access
DBDathan Byonanebye
Dathan Byonanebye
MNMaria S Nabaggala
Maria S Nabaggala
ANAgnes Bwanika Naggirinya
Agnes Bwanika Naggirinya
MLMohammed Lamorde
Mohammed Lamorde
EOElizabeth Oseku
Elizabeth Oseku
RPRosalind Parkes-Ratanshi
Rosalind Parkes-Ratanshi
BACKGROUND Following the successful scale-up of antiretroviral therapy (ART), the focus is now on ensuring good quality of life (QoL) and sustained viral suppression in people living with HIV. The access to mobile technology in the most burdened countries is increasing rapidly, and therefore, mobile health (mHealth) technologies could be leveraged to improve QoL in people living with HIV. However, data on the impact of mHealth tools on the QoL in people living with HIV are limited to the evaluation of SMS text messaging; these are infeasible in high-illiteracy settings. OBJECTIVE The primary and secondary outcomes were to determine the impact of interactive voice response (IVR) technology on Medical Outcomes Study HIV QoL scores and viral suppression at 12 months, respectively. METHODS Within the Call for Life study, ART-experienced and ART-naïve people living with HIV commencing ART were randomized (1:1 ratio) to the control (no IVR support) or intervention arm (daily adherence and pre-appointment reminders, health information tips, and option to report symptoms). The software evaluated was Call for Life Uganda, an IVR technology that is based on the Mobile Technology for Community Health open-source software. Eligibility criteria for participation included access to a phone, fluency in local languages, and provision of consent. The differences in differences (DIDs) were computed, adjusting for baseline HIV RNA and CD4. RESULTS Overall, 600 participants (413 female, 68.8%) were enrolled and followed-up for 12 months. In the intervention arm of 300 participants, 298 (99.3%) opted for IVR and 2 (0.7%) chose SMS text messaging as the mode of receiving reminders and health tips. At 12 months, there was no overall difference in the QoL between the intervention and control arms (DID=0.0; P=.99) or HIV RNA (DID=0.01; P=.94). At 12 months, 124 of the 256 (48.4%) active participants had picked up at least 50% of the calls. In the active intervention participants, high users (received >75% of reminders) had overall higher QoL compared to low users (received <25% of reminders) (92.2 versus 87.8, P=.02). Similarly, high users also had higher QoL scores in the mental health domain (93.1 versus 86.8, P=.008) and better appointment keeping. Similarly, participants with moderate use (51%-75%) had better viral suppression at 12 months (80/94, 85% versus 11/19, 58%, P=.006). CONCLUSIONS Overall, there was high uptake and acceptability of the IVR tool. While we found no overall difference in the QoL and viral suppression between study arms, people living with HIV with higher usage of the tool showed greater improvements in QoL, viral suppression, and appointment keeping. With the declining resources available to HIV programs and the increasing number of people living with HIV accessing ART, IVR technology could be used to support patient care. The tool may be helpful in situations where physical consultations are infeasible, including the current COVID epidemic. CLINICALTRIAL ClinicalTrials.gov NCT02953080; https://clinicaltrials.gov/ct2/show/NCT02953080

9 September 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
EOElizabeth Oseku
Elizabeth Oseku
PMPetra Mariaria
Petra Mariaria
HSHenry Semakula
Henry Semakula
CKClare Allelua Kahuma
Clare Allelua Kahuma
MBMartin Balaba
Martin Balaba
RPRosalind Parkes-Ratanshi
Rosalind Parkes-Ratanshi
Background: Sexually transmitted infections are a significant public health concern, particularly in sub-Saharan Africa, where their prevalence remains high. Promoting awareness and reducing stigma are essential strategies for addressing this challenge, but those affected often have limited access to accurate and culturally appropriate health information. Therefore, innovative solutions are essential to enhance sexual health literacy and encourage informed health-seeking behaviors. Artificial intelligence (AI)–enabled tools, such as chatbots, have emerged as promising avenues for delivering accurate and accessible health information. However, their potential is constrained by the lack of contextualized datasets, which are crucial for ensuring their effectiveness and relevance to diverse populations. Objective: This study aims to develop an open access, contextualized dataset of question-and-answer pairs on sexual health and sexually transmitted infections to support the development and training of digital and AI-enabled health information tools. Methods: Using a crowdsourcing approach, questions are being collected from participants aged ≥15 years via online platforms, paper-based submissions, and in-person interactions at public events across sub-Saharan Africa. Each question will be anonymized and reviewed by medical professionals who will provide accurate, evidence-based answers. The dataset will then undergo processing, including cleaning and tagging for AI training, ensuring adherence to findability, accessibility, interoperability, and reusability principles. The final dataset will be published as open access. Results: Data collection began on June 12, 2024, and is ongoing. The data collection process was piloted in Kigali, Rwanda, where 132 questions were collected. As of August 2025, the study had collected over 5620 question-and-answer pairs. The collected data are undergoing a simultaneous rigorous data processing phase in collaboration with health workers who provide evidence-based answers to the questions and new questions based on their experience in the clinic. The data cleaning and processing will enhance the utility of the data for AI applications. Conclusions: The final dataset will be published as open access in 2025, contributing to the development of AI-driven health tools and promoting public health literacy. International Registered Report Identifier (IRRID): DERR1-10.2196/70005

16 December 2024 in JMIR Preprints
Verified
Preprint
Open access
EOElizabeth Oseku
Elizabeth Oseku
PMPetra Mariaria
Petra Mariaria
HSHenry Semakula
Henry Semakula
CKClare Allelua Kahuma
Clare Allelua Kahuma
MBMartin Balaba
Martin Balaba
RPRosalind Parkes-Ratanshi
Rosalind Parkes-Ratanshi
BACKGROUND Sexually transmitted infections (STIs) are a significant public health concern, particularly in Sub-Saharan Africa, where their prevalence remains high. Promoting awareness and reducing stigma are essential strategies for addressing this challenge, but those affected often have limited access to accurate and culturally appropriate health information. Innovative solutions are therefore essential to enhance sexual health literacy and encourage informed health-seeking behaviors. AI-enabled tools like chatbots have emerged as promising avenues for delivering accurate and accessible health information. However, their potential is constrained by the lack of contextualized datasets, which are crucial for ensuring their effectiveness and relevance to diverse populations. OBJECTIVE This study therefore aims to develop an open-access, contextualized dataset of question-and-answer pairs on sexual health and STIs to support development and training of digital and AI-enabled health information tools. METHODS Using a crowdsourcing approach, questions are being collected from participants aged 15 years and older via online platforms, paper-based submissions, and in-person interactions at public events across Sub-Saharan Africa. Each question will be anonymized and reviewed by medical professionals, who will provide accurate, evidence-based answers. The dataset will then undergo processing, including cleaning and tagging for AI training, ensuring adherence to FAIR principles. The final dataset will be published as open access. RESULTS Data collection began on 12th June 2024 and is ongoing. The data collection process was piloted in Kigali. Data is undergoing cleaning and processing to enhance its utility for AI applications. The final dataset will be published as open access in 2025, contributing CONCLUSIONS This study represents a significant step toward developing accessible evidence-based health information tools, with the potential to increase literacy levels on STIs and improve health-seeking behaviours. The Q&A dataset from this study will enable the development of AI tools to address critical gaps in sexual health education thus fostering informed decision-making.

8 November 2024
Verified
Book Chapter
Closed access
IIInfectious Diseases Institute
Infectious Diseases Institute
EOElizabeth Oseku
Elizabeth Oseku
CAClare Kahuma Allelua
Clare Kahuma Allelua
MNMoreen Nanyonjo
Moreen Nanyonjo
RPRosalind Parkes-Ratanshi
Rosalind Parkes-Ratanshi
This technical report produced by the Hub for Artificial Intelligence in Maternal, Sexual, and Reproductive Health (HASH) details the outcomes of a three-day inception meeting held in December 2022 to launch the ten HASH Phase I subgrantee projects officially. The HASH subgrantees were a combination of students, startup organizations, and established organizations from seven Sub-Saharan African countries. These subgrantees had emerged successfully from a widely advertised competitive Request for Applications. They will conduct 12-18-month research projects on using Artificial Intelligence (AI) to solve identified challenges in Maternal, Sexual, and Reproductive Health (MSRH) in Sub-Saharan Africa. The inception meeting comprised a series of presentations and workshops that facilitated networking, peer learning, expert feedback about the subgrantees' proposed projects, and a framing of the HASH Network.